These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 3329109)

  • 1. Efficacy and tolerability of tenoxicam--an overview.
    Vischer TL
    Eur J Rheumatol Inflamm; 1987; 9(2):51-7. PubMed ID: 3329109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and tolerability of tenoxicam--an overview.
    Vischer TL
    Scand J Rheumatol Suppl; 1987; 65():107-12. PubMed ID: 3317800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical experiences with tenoxicam. Preliminary results of a multicenter study].
    Marcolongo R; Fioravanti A
    Recenti Prog Med; 1991 Apr; 82(4):242-9. PubMed ID: 1857847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Double-blind randomized multicenter study with tenoxicam, piroxicam and diclofenac sodium retard in the treatment of ambulatory patients with arthroses and soft tissue rheumatism].
    Moser U; Waldburger M; Schwarz HA; Gobelet CA
    Schweiz Rundsch Med Prax; 1989 Mar; 78(10):263-9. PubMed ID: 2649954
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of tenoxicam in rheumatology--clinical trial results in Argentina and Brazil.
    Barclay CA; Traballi CA
    Eur J Rheumatol Inflamm; 1987; 9(2):26-50. PubMed ID: 3329108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind study of tenoxicam 20 mg versus piroxicam 20 mg in rheumatoid arthritis.
    Havranek H
    Eur J Rheumatol Inflamm; 1987; 9(2):105-8. PubMed ID: 3329099
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical evaluation of tenoxicam in osteoarthrosis, rheumatoid arthritis and ankylosing spondylitis.
    Standel W; Josenhants G
    Eur J Rheumatol Inflamm; 1985; 8(1):28-38. PubMed ID: 3915885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tenoxicam. An update of its pharmacology and therapeutic efficacy in rheumatic diseases.
    Todd PA; Clissold SP
    Drugs; 1991 Apr; 41(4):625-46. PubMed ID: 1711963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind, parallel clinical trial of tenoxicam (Ro 12-0068) versus piroxicam in patients with ankylosing spondylitis.
    Astorga G
    Eur J Rheumatol Inflamm; 1987; 9(2):70-3. PubMed ID: 3329111
    [No Abstract]   [Full Text] [Related]  

  • 10. Long-term study with Ro 12-0068 (tenoxicam) in the treatment of rheumatoid arthritis.
    Mathias Filho AP; Sidi A
    Eur J Rheumatol Inflamm; 1985; 8(1):3-8. PubMed ID: 3915886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tenoxicam. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
    Gonzalez JP; Todd PA
    Drugs; 1987 Sep; 34(3):289-310. PubMed ID: 3315620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind randomised multicentre study with tenoxicam, piroxicam and diclofenac sodium retard in the treatment of ambulant patients with osteoarthritis and extra-articular rheumatism.
    Moser U; Waldburger H; Schwarz HA; Gobelet CA
    Scand J Rheumatol Suppl; 1989; 80():71-80. PubMed ID: 2688081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ro 12-0068 (tenoxicam) in the treatment of extra-articular inflammatory processes.
    Fiszman P; Perpétuo JB; Sidi A
    Eur J Rheumatol Inflamm; 1985; 8(1):15-20. PubMed ID: 3915883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tenoxicam, a new long-acting non-steroidal anti-inflammatory drug. A placebo-controlled multicenter study].
    Gallo C; Vighi G; Schroeder J
    Clin Ter; 1987 Mar; 120(5):405-14. PubMed ID: 2953540
    [No Abstract]   [Full Text] [Related]  

  • 15. Double-blind parallel study of tenoxicam (20 mg vs. 40 mg) in extra-articular inflammation.
    Tuso L; Jeunet F; Kunovits G; Pasquier M
    Eur J Rheumatol Inflamm; 1987; 9(2):129-32. PubMed ID: 3329105
    [No Abstract]   [Full Text] [Related]  

  • 16. A double-blind parallel study of tenoxicam and piroxicam in patients with osteoarthrosis.
    Bird HA; Hill J; Dixon JS; Looi D; Wright V
    Eur J Rheumatol Inflamm; 1985; 8(1):53-9. PubMed ID: 3915888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind comparison of tenoxicam (Tilcotil, Mobiflex) at two doses against ibuprofen in rheumatoid arthritis.
    Bird HA; Hill J; Lowe JR; Wright V
    Eur J Rheumatol Inflamm; 1984; 7(2):28-32. PubMed ID: 6400518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical experience with tenoxicam: a review.
    Bird HA
    Scand J Rheumatol Suppl; 1987; 65():102-6. PubMed ID: 3317799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A long-term randomised trial on tenoxicam and piroxicam in osteoarthritis of the hip or knee: a 24-month interim report focusing on the 12-24 month interval.
    Lund B; Andersen RB; Fossgreen J; Holm P; Jensen EM; Kirchheiner B; Kryger J; Pichard J
    Eur J Rheumatol Inflamm; 1987; 9(2):58-67. PubMed ID: 3329110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative double blind study of the efficacy and safety of tenoxicam vs. piroxicam in osteoarthritis of knee and hip joints.
    Adelowo OO; Chukwuani CM; Grange JJ; Ojeasebhulo EE; Onabowale BO
    West Afr J Med; 1998; 17(3):194-8. PubMed ID: 9814091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.